Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

STAAR Surgical Company - Common Stock (NQ:STAA)

17.53 +0.06 (+0.34%)
Streaming Delayed Price Updated: 2:18 PM EDT, Jun 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about STAAR Surgical Company - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
STAA Q1 Earnings Call: Tariff Mitigation, Cost Cuts, and China Inventory Reshape Outlook
Medical lens company STAAR Surgical (NASDAQ:STAA) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 44.9% year on year to $42.59 million. Its non-GAAP loss of... 
Via StockStory
Topics World Trade
Exposures Tariff
3 Small-Cap Stocks with Mounting Challenges
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
3 Stocks Under $50 with Mounting Challenges
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
1 Cash-Heavy Stock Worth Your Attention and 2 to Steer Clear Of
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory
Earnings Scheduled For May 7, 2025
Via Benzinga
Analyst Expectations For Staar Surgical's Future
Via Benzinga
Why NASDAQ:STAA Is a Promising High-Growth Stock in the Midst of Consolidation.
Is STAAR SURGICAL CO (NASDAQ:STAA) on the Verge of a Major Breakout as a Strong Growth Stock? 
Via Chartmill
Fortune Brands, Whirlpool, Align Technology, Tandem Diabetes, and STAAR Surgical Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the major indices pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that... 
Via StockStory
Topics Bonds Stocks
Exposures Debt Markets US Equities
STAAR Surgical (NASDAQ:STAA) Exceeds Q1 Expectations
Medical lens company STAAR Surgical (NASDAQ:STAA) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 44.9% year on year to $42.59 million. Its GAAP loss of $1.10... 
Via StockStory
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
NASDAQ:STAA, a growth stock which is not overvalued.
Despite its growth, STAAR SURGICAL CO (NASDAQ:STAA) remains within the realm of affordability. 
Via Chartmill
Despite its growth, NASDAQ:STAA remains within the realm of affordability.
STAAR SURGICAL CO (NASDAQ:STAA), a growth stock which is not overvalued. 
Via Chartmill
STAAR Surgical (STAA) Reports Q1: Everything You Need To Know Ahead Of Earnings
Medical lens company STAAR Surgical (NASDAQ:STAA) will be reporting results tomorrow after market hours. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
This Dycom Industries Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Spotting Winners: STAAR Surgical (NASDAQ:STAA) And Medical Devices & Supplies - Specialty Stocks In Q4
Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including STAAR Surgical (NASDAQ:STAA) and its peers. 
Via StockStory
Medical Devices & Supplies - Specialty Stocks Q3 Recap: Benchmarking STAAR Surgical (NASDAQ:STAA)
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including STAAR Surgical... 
Via StockStory
Analyst Expectations For Staar Surgical's Future
Via Benzinga
Redfin, Mineralys Therapeutics, Trevi Therapeutics And Other Big Stocks Moving Higher On Monday
Via Benzinga
3 Stocks Under $50 in Hot Water
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q3 Earnings: STAAR Surgical (NASDAQ:STAA) Vs The Rest Of The Pack
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at STAAR Surgical (NASDAQ:STAA) and the best... 
Via StockStory
Keep an eye on the top gainers and losers in Wednesday's session.
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements. 
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
Eye Lens Maker Staar Surgical Stock Sinks As Sales Drop To $49 Million, Analyst Downgrades
Staar Surgical posted a Q4 2024 revenue decline due to weak China sales. The company plans cost-cutting measures. 
Via Benzinga
This PPG Industries Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Via Benzinga
Teradata Posts Weak Revenue, Joins Lyft, Vertiv, Zillow And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Upstart Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Which stocks are moving after the closing bell on Tuesday?
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
Don't overlook NASDAQ:STAA—a stock with solid growth prospects and a reasonable valuation.
STAAR SURGICAL CO was identified as a growth stock that isn't overvalued. NASDAQ:STAA is excelling in various growth indicators while maintaining a solid financial footing. 
Via Chartmill
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.